🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to measure two different formulations of BG000...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT01069913
Treatments Being Tested
The primary objective of the study is to determine if dimethyl fumarate (DM...
Status
Completed
Location
Research site
Start Date
2015-11-06
Trial ID
NCT02471560
Treatments Being Tested
The primary objective of the study is to evaluate whether premedication wit...
Status
Completed
Location
Research Site
Start Date
2012-04
Trial ID
NCT01568112
Treatments Being Tested
The primary objective of the study is to determine the effect of bismuth su...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01915901
The investigators conduct this study to investigate whether oral administra...
Status
Terminated
Location
Xuanwu Hospital, Capital Medical University
Start Date
2021-12-01
Trial ID
NCT04890353
Treatments Being Tested
This is an observational, non-interventional, multicenter, open-label study...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2022-05-10
Trial ID
NCT05344469
To determine if treatment with BG00012 can decrease the number of MS relaps...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00420212
The primary objective of the study is to evaluate relapse activity, as meas...
Status
Completed
Location
Research Site
Start Date
2014-07
Trial ID
NCT02159573
Treatments Being Tested
STATURE is a prospective observational six-arm translation multi-site study...
Status
Unknown
Location
Monash University
Start Date
2020-09-25
Trial ID
NCT04676204
Treatments Being Tested
This is a randomized, controlled, multicenter, open-label Phase IIa clinica...
Status
Recruiting
Location
Beijing Tiantan Hospital, Capital Medical University
Start Date
2026-08
Trial ID
NCT07776743
Treatments Being Tested